These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30911942)

  • 1. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy.
    Reyes-Loyola P; Rodríguez-Henríquez P; Ballinas-Verdugo MA; Amezcua-Castillo LM; Juárez-Vicuña Y; Jiménez-Rojas V; Márquez-Velasco R; Sánchez-Muñoz F; Amezcua-Guerra LM
    Clin Rheumatol; 2019 May; 38(5):1367-1373. PubMed ID: 30911942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Intercellular Adhesion Molecule-1, -2, -3 Plasma Levels and Disease Activity of Ankylosing Spondylitis in the Chinese Han Population.
    Liu R; Yue Z; Peng X; Wang X; Feng Z; Wan L
    Spine (Phila Pa 1976); 2016 May; 41(10):E618-24. PubMed ID: 26641849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
    Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
    Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
    Ciechomska M; Bonek K; Merdas M; Zarecki P; Swierkot J; Gluszko P; Bogunia-Kubik K; Maslinski W
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):389-397. PubMed ID: 29744553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.
    Lai NS; Yu HC; Chen HC; Yu CL; Huang HB; Lu MC
    Clin Exp Immunol; 2013 Jul; 173(1):47-57. PubMed ID: 23607629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis.
    Prajzlerová K; Komarc M; Forejtová Š; Pavelka K; Vencovský J; Šenolt L; Filková M
    Physiol Res; 2021 Apr; 70(2):255-264. PubMed ID: 33676382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA let-7i-3p affects osteoblast differentiation in ankylosing spondylitis via targeting PDK1.
    Sun S; Xu Y; Zhu Z; Kong D; Liu H; Zhou Z; Wang L
    Cell Cycle; 2021 Jun; 20(12):1209-1219. PubMed ID: 34048311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
    Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
    Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 3A in Ankylosing Spondylitis.
    Liao HT; Lin YF; Chou CT; Tsai CY
    J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
    Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
    Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
    Inci U; Yildiz A; Batmaz I; Tekbas E
    Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis.
    Yang W; Yan X; Xia Q; Tao Q; Gan X; Zhang Y; Chen Z; Kong W
    Mod Rheumatol; 2019 Jan; 29(1):173-180. PubMed ID: 29542383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.
    Konsta M; Bamias G; Tektonidou MG; Christopoulos P; Iliopoulos A; Sfikakis PP
    Rheumatology (Oxford); 2013 Mar; 52(3):448-51. PubMed ID: 23204549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis.
    Dong Y; Li P; Xu T; Bi L
    Clin Rheumatol; 2019 Jun; 38(6):1587-1594. PubMed ID: 30747393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients.
    Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; Montepaone M; Alessandri C; Valesini G; Lubrano E
    Clin Exp Rheumatol; 2017; 35(2):313-316. PubMed ID: 27782869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.